Shareholders Say Auspex CEO Rushed $3.5B Teva Merger
A top Auspex Pharmaceuticals Inc. officer was serving his own ambitions when he allegedly rushed a $3.5 billion, all-cash merger with Teva Pharmaceuticals Industries Ltd. last year despite other prospects, an...To view the full article, register now.
Already a subscriber? Click here to view full article